Two novel serum biomarkers for endometriosis screened by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and their change after laparoscopic removal of endometriosis

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1221-1227

  Jing, Jianhong ^a   Qiao, Yuhuan ^a   Suginami, Hiroshi ^b,d   Taniguchi, Fumiaki ^b   Shi, Huirong ^a   Wang, Xiuli ^c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c the 150th Central Hospital   (China)

^d Takanohara Central Hospital   (Japan)

Author keywords

biomarker; diagnosis; Endometriosis; proteomics; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; ENDOMETRIOSIS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UTERINE DISEASES; YOUNG ADULT;

EID: 70349580354     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.078     Document Type: Article

References (24)

1. Sangi-Haghpeykar H., and Poindexter A.N. Epidemiology of endometriosis among parous women. Obstet Gynecol 85 (1995) 983-992
2. Sampson J.A. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-425
3. Koninckx P.R., and Kennedy S. Implantation versus infiltration: the Samposon versus the endometriosis theory. Gynecol Obstet Ivest 47 (1999) 3-10
4. Kennedy S.H., Mardon H., and Barlow D.H. Familial endometriosis. J Assist Reprod Gen 12 (1995) 32-34
5. Audebert A. Endometriosis coaching. Gynecol Obstet Fertil 34 (2006) 329-336
6. Hershlag A., and Markovitz J. Is laparoscopy back?. Fertil Steril 84 (2005) 1585-1586
7. Bast Jr. R.C., Xu F.J., Yu Y.H., Barnhill S., Zhang Z., and Mill G.B. CA125: the past and the future. Int J Biol Markers 13 (1998) 179-187
8. Chen F.P., Song Y.K., Lee N., and Lo S.K. The use of serum CA125 as a marker for endometriosis in patient with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand 77 (1998) 665-670
9. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
10. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., and Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48 (2002) 1296-1304
11. Adam B.L., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62 (2002) 3609-3614
12. Petricoin E.F., Ornstein D.K., Paweletz C.P., Ardekani A., Hackett P.S., Hitt B.A., et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94 (2002) 1576-1578
13. Poon T.C., Yip T.T., Chan A.T., Yip C., Yip V., Mok T.S., et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49 (2003) 752-760
14. Vlahou A., Schellhammer P.F., Mendrinos S., Patel K., Kondylis F.I., Gong L., et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158 (2001) 1491-1502
15. Rosty C., Christa L., Kuzdzal S., Baldwin W.M., Zahurak M.L., Carnot F., et al. Identification of hepato carcinoma-intestine-pancreas/pancreatitis associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 62 (2002) 1868-1875
16. Yanagisawa K., Shyr Y., Xu B.J., Massion P.P., Larsen P.H., White B.C., et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362 (2003) 433-439
17. Abrao M.S., Podgaec S., Filho B.M., Ramos L.O., Pinotti J.A., and de Oliveira R.M. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod 12 (1997) 2523-2527
18. Bedaiwy M.A., Falcone T., Sharma R.K., Goldberg J.M., Attarran M., Nelson D.R., et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17 (2002) 426-431
19. Chapman K. The protein chip BioMarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 30 (2002) 82-87
20. Rogers M.A., Clarke P., Noble J., Munro N.P., Paul A., Selby P.J., et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 63 (2003) 6971-6983
21. Shiwa M., Nishimura Y., Wakatabe R., Fukawa A., Arikuni H., Ota H., et al. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun 309 (2003) 18-25
22. Suginami H., Tokushige M., Taniguchi F., and Kitaoka Y. Complete removal of endometriosis improves fecundity. Gynecol Obstet Invest 53 Suppl (2002) 12-18
23. Wang L., Zheng W., Yu J., Jiang W., Mu L., and Zhang S. Artificial neural networks combined with surface-enhanced laser desorption/ionization mass spectra distinguish endometriosis from healthy population. Fertil Steril 88 (2007) 1700-1702
24. Liu H., Lang J., Zhou Q., Shan D., and Li Q. Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Fertil Steril 87 (2007) 988-990